Listed

Humana Inc

HUMNYSECIK 49071FinancialsFiscal year ends Dec 31

Latest reported revenue, Q1 FY2026$39.65bnRevenue, Q1 FY2026, three months to 2026-03-31$39.65bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-29, accession 0000049071-26-000023.Report this figureThree months to Mar 31, 2026, from the 10-Q filed Apr 29, 2026.

Latest quarter: Q1 FY2026

Three months to Mar 31, 2026, against the same quarter a year earlier.

  • Revenue$39.65bnRevenue, Q1 FY2026, three months to 2026-03-31$39.65bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-29, accession 0000049071-26-000023.Report this figure+23.5% on a year earlier
  • Gross marginnot reported (Gross profit not reported)No year-earlier figure to compare
  • Operating margin4.4%Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $1.75bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-29, accession 0000049071-26-000023.Revenue: $39.65bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-29, accession 0000049071-26-000023.Report this figure−1.8 pts on a year earlier
  • Net margin3.0%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $1.19bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-29, accession 0000049071-26-000023.Revenue: $39.65bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-29, accession 0000049071-26-000023.Report this figure−0.9 pts on a year earlier
  • Diluted EPS$9.83Diluted EPS, Q1 FY2026, three months to 2026-03-31$9.83 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-29, accession 0000049071-26-000023.Report this figure−4.6% on a year earlier
  • Free cash flow$1.13bnFree cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $1.25bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-29, accession 0000049071-26-000023.Capital expenditure: $121.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-29, accession 0000049071-26-000023.Report this figure+380.1% on a year earlier

Last eight quarters

Full statements
Revenue$39.65bnOperating margin 4.4%
Diluted EPS$9.83, Q1 FY2026
Free cash flow$1.13bn, Q1 FY2026
Humana Inc, key figures for the last eight quarters
Line itemUnitQ2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Shape over the periods
Revenue$bn29.5Revenue, Q2 FY2024, three months to 2024-06-30$29.54bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-07-30, accession 0000049071-25-000042.Report this figure29.4Revenue, Q3 FY2024, three months to 2024-09-30$29.40bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-05, accession 0000049071-25-000057.Report this figure29.2Revenue, Q4 FY2024, three months to 2024-12-31$29.21bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-19, accession 0000049071-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure32.1Revenue, Q1 FY2025, three months to 2025-03-31$32.11bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-29, accession 0000049071-26-000023.Report this figure32.4Revenue, Q2 FY2025, three months to 2025-06-30$32.39bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-07-30, accession 0000049071-25-000042.Report this figure32.6Revenue, Q3 FY2025, three months to 2025-09-30$32.65bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-05, accession 0000049071-25-000057.Report this figure32.5Revenue, Q4 FY2025, three months to 2025-12-31$32.52bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-19, accession 0000049071-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure39.6Revenue, Q1 FY2026, three months to 2026-03-31$39.65bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-29, accession 0000049071-26-000023.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%3.9%Operating margin, Q2 FY2024, three months to 2024-06-30. operating income / revenueOperating income: $1.14bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-30, accession 0000049071-25-000042.Revenue: $29.54bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-07-30, accession 0000049071-25-000042.Report this figure2.5%Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: $728.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0000049071-25-000057.Revenue: $29.40bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-05, accession 0000049071-25-000057.Report this figure(1.9%)Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: −$543.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-19, accession 0000049071-26-000009. Derived: 12-month figure less the 9-month figure.Revenue: $29.21bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-19, accession 0000049071-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure6.3%Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $2.01bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-29, accession 0000049071-26-000023.Revenue: $32.11bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-29, accession 0000049071-26-000023.Report this figure3.4%Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $1.10bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-30, accession 0000049071-25-000042.Revenue: $32.39bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-07-30, accession 0000049071-25-000042.Report this figure1.2%Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: $400.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0000049071-25-000057.Revenue: $32.65bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-05, accession 0000049071-25-000057.Report this figure(2.5%)Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: −$808.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-19, accession 0000049071-26-000009. Derived: 12-month figure less the 9-month figure.Revenue: $32.52bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-19, accession 0000049071-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure4.4%Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $1.75bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-29, accession 0000049071-26-000023.Revenue: $39.65bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-29, accession 0000049071-26-000023.Report this figure
Net margin%2.3%Net margin, Q2 FY2024, three months to 2024-06-30. net income / revenueNet income: $679.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-07-30, accession 0000049071-25-000042.Revenue: $29.54bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-07-30, accession 0000049071-25-000042.Report this figure1.6%Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: $480.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0000049071-25-000057.Revenue: $29.40bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-05, accession 0000049071-25-000057.Report this figure(2.4%)Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: −$693.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-19, accession 0000049071-26-000009. Derived: 12-month figure less the 9-month figure.Revenue: $29.21bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-19, accession 0000049071-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure3.9%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $1.24bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-29, accession 0000049071-26-000023.Revenue: $32.11bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-29, accession 0000049071-26-000023.Report this figure1.7%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $545.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-07-30, accession 0000049071-25-000042.Revenue: $32.39bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-07-30, accession 0000049071-25-000042.Report this figure0.6%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $195.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0000049071-25-000057.Revenue: $32.65bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-05, accession 0000049071-25-000057.Report this figure(2.4%)Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: −$796.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-19, accession 0000049071-26-000009. Derived: 12-month figure less the 9-month figure.Revenue: $32.52bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-19, accession 0000049071-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure3.0%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $1.19bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-29, accession 0000049071-26-000023.Revenue: $39.65bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-29, accession 0000049071-26-000023.Report this figure
Diluted EPS$ per share5.62Diluted EPS, Q2 FY2024, three months to 2024-06-30$5.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-30, accession 0000049071-25-000042.Report this figure3.98Diluted EPS, Q3 FY2024, three months to 2024-09-30$3.98 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0000049071-25-000057.Report this figurenot reported (Diluted EPS not reported)10.30Diluted EPS, Q1 FY2025, three months to 2025-03-31$10.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-29, accession 0000049071-26-000023.Report this figure4.51Diluted EPS, Q2 FY2025, three months to 2025-06-30$4.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-30, accession 0000049071-25-000042.Report this figure1.62Diluted EPS, Q3 FY2025, three months to 2025-09-30$1.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0000049071-25-000057.Report this figurenot reported (Diluted EPS not reported)9.83Diluted EPS, Q1 FY2026, three months to 2026-03-31$9.83 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-29, accession 0000049071-26-000023.Report this figure
Free cash flow$bn1.1Free cash flow, Q2 FY2024, three months to 2024-06-30. operating cash flow − capital expenditureOperating cash flow: $1.21bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-30, accession 0000049071-25-000042. Derived: 6-month figure less the 3-month figure.Capital expenditure: $114.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-30, accession 0000049071-25-000042. Derived: 6-month figure less the 3-month figure.Report this figure1.7Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $1.86bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0000049071-25-000057. Derived: 9-month figure less the 6-month figure.Capital expenditure: $130.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0000049071-25-000057. Derived: 9-month figure less the 6-month figure.Report this figure(0.7)Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$528.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0000049071-26-000009. Derived: 12-month figure less the 9-month figure.Capital expenditure: $154.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-19, accession 0000049071-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure0.2Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $331.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-29, accession 0000049071-26-000023.Capital expenditure: $95.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-29, accession 0000049071-26-000023.Report this figure1.2Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $1.27bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-30, accession 0000049071-25-000042. Derived: 6-month figure less the 3-month figure.Capital expenditure: $114.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-30, accession 0000049071-25-000042. Derived: 6-month figure less the 3-month figure.Report this figure0.8Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $971.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0000049071-25-000057. Derived: 9-month figure less the 6-month figure.Capital expenditure: $135.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0000049071-25-000057. Derived: 9-month figure less the 6-month figure.Report this figure(1.9)Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$1.65bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0000049071-26-000009. Derived: 12-month figure less the 9-month figure.Capital expenditure: $202.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-19, accession 0000049071-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure1.1Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $1.25bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-29, accession 0000049071-26-000023.Capital expenditure: $121.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-29, accession 0000049071-26-000023.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$129.66bnOperating margin 2.1%
Diluted EPS$9.84, FY2025
Free cash flow$375.0m, FY2025
Humana Inc, key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$bn83.1Revenue, FY2021, twelve months to 2021-12-31$83.06bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-15, accession 0000049071-24-000012.Report this figure92.9Revenue, FY2022, twelve months to 2022-12-31$92.87bn. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-20, accession 0000049071-25-000007.Report this figure106Revenue, FY2023, twelve months to 2023-12-31$106.37bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-19, accession 0000049071-26-000009.Report this figure118Revenue, FY2024, twelve months to 2024-12-31$117.76bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-19, accession 0000049071-26-000009.Report this figure130Revenue, FY2025, twelve months to 2025-12-31$129.66bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-19, accession 0000049071-26-000009.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%3.8%Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: $3.15bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-15, accession 0000049071-24-000012.Revenue: $83.06bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-15, accession 0000049071-24-000012.Report this figure4.1%Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: $3.80bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-20, accession 0000049071-25-000007.Revenue: $92.87bn. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-20, accession 0000049071-25-000007.Report this figure3.8%Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: $4.01bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-19, accession 0000049071-26-000009.Revenue: $106.37bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-19, accession 0000049071-26-000009.Report this figure2.2%Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: $2.56bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-19, accession 0000049071-26-000009.Revenue: $117.76bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-19, accession 0000049071-26-000009.Report this figure2.1%Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: $2.70bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-19, accession 0000049071-26-000009.Revenue: $129.66bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-19, accession 0000049071-26-000009.Report this figure
Net margin%3.5%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $2.93bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-15, accession 0000049071-24-000012.Revenue: $83.06bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-15, accession 0000049071-24-000012.Report this figure3.0%Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: $2.81bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-20, accession 0000049071-25-000007.Revenue: $92.87bn. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-20, accession 0000049071-25-000007.Report this figure2.3%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $2.49bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-19, accession 0000049071-26-000009.Revenue: $106.37bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-19, accession 0000049071-26-000009.Report this figure1.0%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $1.21bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-19, accession 0000049071-26-000009.Revenue: $117.76bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-19, accession 0000049071-26-000009.Report this figure0.9%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $1.19bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-19, accession 0000049071-26-000009.Revenue: $129.66bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-19, accession 0000049071-26-000009.Report this figure
Diluted EPS$ per share22.67Diluted EPS, FY2021, twelve months to 2021-12-31$22.67 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-15, accession 0000049071-24-000012.Report this figure22.08Diluted EPS, FY2022, twelve months to 2022-12-31$22.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-20, accession 0000049071-25-000007.Report this figure20.00Diluted EPS, FY2023, twelve months to 2023-12-31$20.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-19, accession 0000049071-26-000009.Report this figure9.98Diluted EPS, FY2024, twelve months to 2024-12-31$9.98 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-19, accession 0000049071-26-000009.Report this figure9.84Diluted EPS, FY2025, twelve months to 2025-12-31$9.84 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-19, accession 0000049071-26-000009.Report this figure
Free cash flow$bn0.9Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $2.26bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-15, accession 0000049071-24-000012.Capital expenditure: $1.34bn. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-15, accession 0000049071-24-000012.Report this figure3.5Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: $4.59bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-20, accession 0000049071-25-000007.Capital expenditure: $1.14bn. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-20, accession 0000049071-25-000007.Report this figure3.0Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $3.98bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0000049071-26-000009.Capital expenditure: $1.00bn. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-19, accession 0000049071-26-000009.Report this figure2.4Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $2.97bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0000049071-26-000009.Capital expenditure: $575.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-19, accession 0000049071-26-000009.Report this figure0.4Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $921.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0000049071-26-000009.Capital expenditure: $546.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-19, accession 0000049071-26-000009.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Humana Inc
FundQuarter endedReported valueSharesPut or callChange on the quarter before
Dodge & Cox2026-06-30$4.35bn10,940,380Reduced−440,293
BlackRock, Inc.2026-06-30$4.14bn10,417,803Added+218,748
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$3.12bn7,843,620Added+4,858
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$2.31bn5,818,956Added+10,521
STATE STREET CORP2026-06-30$2.17bn5,457,072Added+4,080
PZENA INVESTMENT MANAGEMENT LLC2026-06-30$1.75bn4,403,136Reduced−1,067,846
MASSACHUSETTS FINANCIAL SERVICES CO /MA/2026-06-30$1.66bn3,578,245Reduced−904,125
EAGLE CAPITAL MANAGEMENT LLC2026-06-30$1.53bn3,846,762Added+879,688
Sessa Capital IM, L.P.2026-06-30$1.48bn3,727,740Unchanged
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$1.34bn3,369,757Added+43,062

Recent filings

All 2,268 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Humana Inc, recent filings
FiledFormWhat it isAccession number
2026-10-1310:04 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000049071-26-000060
2026-10-0910:01 ET8-K7.01 Regulation FD disclosure0000049071-26-000057
2026-09-0111:30 ET8-K7.01 Regulation FD disclosure0000049071-26-000052
2026-07-2918:11 ET10-QQuarterly reportPeriod 2026-06-300000049071-26-000050
2026-07-2911:00 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000049071-26-000047
2026-07-2910:19 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000049071-26-000045
2026-06-0110:37 ET8-K7.01 Regulation FD disclosure0000049071-26-000027
2026-05-1920:30 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0000049071-26-000025
2026-04-2918:09 ET10-QQuarterly reportPeriod 2026-03-310000049071-26-000023
2026-04-2910:06 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000049071-26-000021

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 19, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league

About the filer

CIK
49071
Tickers
HUM
Exchange
NYSE
SIC code
6324 Hospital & Medical Service Plans
Sector
Financials
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:19 ET. Listed shows no prices and gives no investment advice.